These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 25661535)

  • 1. The dipeptidyl peptidase-IV inhibitor inhibits the expression of vascular adhesion molecules and inflammatory cytokines in HUVECs via Akt- and AMPK-dependent mechanisms.
    Hwang HJ; Chung HS; Jung TW; Ryu JY; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ
    Mol Cell Endocrinol; 2015 Apr; 405():25-34. PubMed ID: 25661535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression.
    Hwang HJ; Jung TW; Kim BH; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ
    Biochem Pharmacol; 2015 Nov; 98(1):157-66. PubMed ID: 26297911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl petidase-IV inhibitor (gemigliptin) inhibits tunicamycin-induced endoplasmic reticulum stress, apoptosis and inflammation in H9c2 cardiomyocytes.
    Hwang HJ; Jung TW; Ryu JY; Hong HC; Choi HY; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):1-7. PubMed ID: 24813659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZLJ-6, a novel COX/5-LOX inhibitor, attenuates TNF-α-induced endothelial E-selectin, ICAM-1 and VCAM-1 expression and monocyte-endothelial interactions via a COX/5-LOX-independent mechanism.
    Chen L; Zhao Q; Wang XL; You R; Zhang YH; Ji H; Lai YS
    Vascul Pharmacol; 2011; 55(5-6):135-42. PubMed ID: 21777697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-
    Lee N; Heo YJ; Choi SE; Jeon JY; Han SJ; Kim DJ; Kang Y; Lee KW; Kim HJ
    J Immunol Res; 2021; 2021():9944880. PubMed ID: 34124273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation.
    Choi SH; Park S; Oh CJ; Leem J; Park KG; Lee IK
    Vascul Pharmacol; 2015 Oct; 73():11-9. PubMed ID: 26187356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells.
    Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Endocrine; 2018 Feb; 59(2):383-394. PubMed ID: 29285650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemigliptin Inhibits Interleukin-1β-Induced Endothelial-Mesenchymal Transition via Canonical-Bone Morphogenetic Protein Pathway.
    Hong OK; Lee SS; Yoo SJ; Lee MK; Kim MK; Baek KH; Song KH; Kwon HS
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):384-395. PubMed ID: 32615723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricin, flavonoid from Njavara reduces inflammatory responses in hPBMCs by modulating the p38MAPK and PI3K/Akt pathways and prevents inflammation associated endothelial dysfunction in HUVECs.
    Shalini V; Pushpan CK; G S; A J; A H
    Immunobiology; 2016 Feb; 221(2):137-44. PubMed ID: 26514297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells.
    Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Tumour Biol; 2017 Oct; 39(10):1010428317722068. PubMed ID: 28982310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochanin A inhibits lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells.
    Ming X; Ding M; Zhai B; Xiao L; Piao T; Liu M
    Life Sci; 2015 Sep; 136():36-41. PubMed ID: 26141992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnosol inhibits cell adhesion molecules and chemokine expression by tumor necrosis factor-α in human umbilical vein endothelial cells through the nuclear factor-κB and mitogen-activated protein kinase pathways.
    Yao H; Chen Y; Zhang L; He X; He X; Lian L; Wu X; Lan P
    Mol Med Rep; 2014 Feb; 9(2):476-80. PubMed ID: 24316968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycolipids from spinach suppress LPS-induced vascular inflammation through eNOS and NK-κB signaling.
    Ishii M; Nakahara T; Araho D; Murakami J; Nishimura M
    Biomed Pharmacother; 2017 Jul; 91():111-120. PubMed ID: 28448865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextromethorphan attenuates LPS-induced adhesion molecule expression in human endothelial cells.
    Jiang SJ; Hsu SY; Deng CR; Huang HC; Liu SL; Shi GY; Wu HL
    Microcirculation; 2013 Feb; 20(2):190-201. PubMed ID: 23140507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acanthoic acid inhibits LPS-induced inflammatory response by activating LXRα in human umbilical vein endothelial cells.
    Li Y; Zhang XS; Yu JL
    Int Immunopharmacol; 2016 Mar; 32():111-115. PubMed ID: 26803523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells.
    Hattori Y; Suzuki K; Tomizawa A; Hirama N; Okayasu T; Hattori S; Satoh H; Akimoto K; Kasai K
    Cardiovasc Res; 2009 Jan; 81(1):133-9. PubMed ID: 18703532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LECT2 induces atherosclerotic inflammatory reaction via CD209 receptor-mediated JNK phosphorylation in human endothelial cells.
    Hwang HJ; Jung TW; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ
    Metabolism; 2015 Sep; 64(9):1175-82. PubMed ID: 26123523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells.
    Hattori Y; Suzuki K; Hattori S; Kasai K
    Hypertension; 2006 Jun; 47(6):1183-8. PubMed ID: 16636195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereocalpin A inhibits the expression of adhesion molecules in activated vascular smooth muscle cells.
    Byeon HE; Park BK; Yim JH; Lee HK; Moon EY; Rhee DK; Pyo S
    Int Immunopharmacol; 2012 Feb; 12(2):315-25. PubMed ID: 22210374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.